Trial
NCT02939807
A Phase II Study of ABC294640 as Monotherapy in Patients With Advanced Hepatocellular Carcinoma
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Medical University of South Carolina
Collaborators
National Cancer Institute (NCI); Apogee Biotechnology Corporation
Condition
Carcinoma, Hepatocellular
Intervention
ABC294640
Why stopped
study is being rewritten for different disease population
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-04-27